Epirubicin carboplatin and 5-fluorouracil (ECarboF) chemotherapy in metastatic hormone refractory prostate cancer

The aim of this study was to examine the efficacy and toxicity of the epirubicin, carboplatin and 5-fluorouracil (ECarboF) regime in patients aged 70 or less with metastatic prostate cancer resistant to LHRH analogues. The majority of patients had previously received steroids as part of their system...

Descripción completa

Detalles Bibliográficos
Autores principales: Birtle, A J, Newby, J C, Harland, S J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410017/
https://www.ncbi.nlm.nih.gov/pubmed/15381936
http://dx.doi.org/10.1038/sj.bjc.6602177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410017/
https://www.ncbi.nlm.nih.gov/pubmed/15381936
http://dx.doi.org/10.1038/sj.bjc.6602177

Ejemplares similares